# Randomized Study of HLA-mismatched DSI to Treat Relapse Leukemia After HLA- Matched Transplantation

> **NCT02028650** · — · COMPLETED · sponsor: **huishengai** · enrollment: 20 (actual)

## Conditions studied

- Relapse Leukemia

## Interventions

- **BIOLOGICAL:** the first donor's stem cell
- **BIOLOGICAL:** the second donor's stem cell

## Key facts

- **NCT ID:** NCT02028650
- **Lead sponsor:** huishengai
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2013-02
- **Final completion:** 2014-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02028650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02028650, "Randomized Study of HLA-mismatched DSI to Treat Relapse Leukemia After HLA- Matched Transplantation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02028650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*